FDA Person
FDADavid L. Chon
View detailed information about David L. Chon, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 103 inspections of 98 companies, 2016–2026.
Inspections (103)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 18, 2026 | Bethany Brown, PhD, MSCS | Not classified | Blood and Blood Products | #1341282 |
| August 28, 2026 | EMD Serono, Inc. | Not classified | #1334410 | |
| August 14, 2026 | Michael E. Ivan, MD | Not classified | #1332674 | |
| June 26, 2026 | StageBio | Not classified | #1328812 | |
| May 1, 2026 | Eduardo E. Rodriguez-Araya, MD | Not classified | Bioresearch Monitoring | #1315028 |
| March 13, 2026 | Bradly S. Goodman, M.D. | Not classified | #1318068 | |
| February 27, 2026 | Ziv J. Haskal, MD | NAI | Product Evaluation: Medical Devices | #1305076 |
| January 29, 2026 | Bioreliance Corporation | VAI | Bioresearch Monitoring: Human Drugs | #1295306 |
| December 19, 2025 | Novocure GmbH | Not classified | #1298666 | |
| November 21, 2025 | Georgetown University IRB | Not classified | #1293802 | |
| October 29, 2025 | Vemulkonda Koneti Rao, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1289862 |
| October 9, 2025 | George Hartley Freeman, M.D. | Not classified | #1290506 | |
| September 12, 2025 | Johns Hopkins University School of Medicine IRB | Not classified | #1283898 | |
| August 28, 2025 | GUERBET LLC | VAI | Postmarketing Surveillance and Epidemiology: Human Drugs | #1280300 |
| August 11, 2025 | Jonathan B. Cohen, M.D. | Not classified | #1285618 | |
| July 4, 2025 | Maria Luz Couce Pico, M.D. | Not classified | #1278411 | |
| June 27, 2025 | Gloria Lopez Sobrino | Not classified | #1276231 | |
| June 23, 2025 | Gustavo Adolfo De Luiz Martinez | Not classified | #1277357 | |
| June 2, 2025 | Rapa Therapeutics LLC | VAI | Human Cellular, Tissue, and Gene Therapies | #1272289 |
| May 6, 2025 | Lung Bioengineering Inc. | Not classified | #1270620 |
Documents (38)
- EIR · Advarra IRB · May 27, 2021
- 483 · GUERBET LLC · August 28, 2025
- EIR · Labcorp Early Development Laboratories, Inc. · August 31, 2021
- EIR · Ira L. Berger, M.D. · November 13, 2020
- 483 · Vemulkonda Koneti Rao, M.D. · October 29, 2025
- 483 · Nicholas Ah Mew, M.D. · July 17, 2019
- 483 · Mark Roschewski, M.D. · May 11, 2021
- 483 · Milestone Pharmaceutiques Inc · November 19, 2024
- 483 · William A. Gahl, MD, PhD · December 19, 2024
- 483 · PPD Development, L.P. · January 31, 2025
- 483 · James A. Simon, MD · May 5, 2023
- EIR · Wayne Farnsworth, MD · June 27, 2023
- EIR · Johns Hopkins University Laboratory · June 14, 2019
- 483 · Augusto D. Pichard, M.D. · February 9, 2016
- 483 · AstraZeneca Pharmaceuticals, LP · January 30, 2018
- 483 · Jeffrey S. Dome, M.D. · April 12, 2021
- 483 · Institute for In Vitro Sciences, Inc. · June 1, 2022
- 483 · National Cancer Institute Central IRB · August 9, 2022
- 483 · David L. Scott, MD · November 18, 2022
- EIR · Precision Nuclear of Virginia, LLC · November 19, 2015
- 483 · Amarex Clinical Research, LLC · December 29, 2021
- EIR · Dp Clinical Inc · November 13, 2017
- 483 · Robert S. Call, M.D. · October 19, 2022
- 483 · Vanda Pharmaceuticals Inc · March 12, 2024
- 483 · Zsolt Szabo, M.D. · November 22, 2019
- 483 · Reveragen Biopharma Inc. · March 6, 2023
- EIR · AstraZeneca Pharmaceuticals, LP · January 30, 2018
- 483 · Dr. James A. Thompson, M.D. · September 27, 2023
- 483 · Belmora LLC · September 13, 2017
- EIR · Experimental Pathology Laboratories, Inc. · November 13, 2018
- 483 · Wayne Farnsworth, MD · June 27, 2023
- 483 · H. Henry Li, MD · March 24, 2023
- 483 · Mark Roschewski, M.D. · April 15, 2024
- 483 · Bioreliance Corporation · January 29, 2026
- 483 · Rapa Therapeutics LLC · June 2, 2025
- 483 · National Cancer Institute (NCI) · November 15, 2016
- 483 · U.S. Army Medical Research Institute of Infectious Diseases · February 3, 2020
- 483 · University of Virginia Health System · June 18, 2026
Frequently inspected with (10)
Lucilla Facchin
9 shared
Melanie N. Daniels
investigator
6 shared
Brittany L. Carpenter
investigator
4 shared
Young M. Yoon
investigator
4 shared
Anne E. Johnson
Senior Science Advisor
2 shared
Bei Yu
issuing_officer
2 shared
John Dan
investigator
2 shared
Lee Hong Pai Scherf
2 shared
Braedyn K. Kromer
1 shared
Chrissy J. Cochran
1 shared
Person Information
Name
David L. Chon
Title
Consumer Safety Officer/BIMO Investigator
Role
INVESTIGATOR
ID: 227b9c21-14c4-442b-bdc3-ad167567fd92
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.